Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20220613008
TCTR20220613008
Recruiting
N/A

Characterization of circulating tumour cells undergoing epithelial-mesenchymal transition in hepatocellular carcinoma and its revlevance in tumor staging modalities

Faculty of Medicine, Chiang Mai University0 sites44 target enrollmentJune 13, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHepatocellular carcinomaCirculating tumor cells, Hepatocellular carcinoma, Epithelial-mesenchymal transition, Phenotype, prognosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Faculty of Medicine, Chiang Mai University
Enrollment
44
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2022
End Date
December 17, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •The HCC patients are recruited at Maharaj Nakorn Chiang Mai Hospital. Principal inclusion criteria are: 1\) Patients diagnosed with HCC according to American Association for Study of Liver Disease (AASLD) and 2\) no prior anti\-cancer treatment.

Exclusion Criteria

  • •Protocols exclude HCC patients with a history of other cancer.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
ogistics of Circulating Tumor Cells in Peripheral Blood Collection in Patients with Metastatic Prostate Cancergemetastaseerd prostaatkankermetastatic prostate cancer10027476
NL-OMON40759eids Universitair Medisch Centrum10
Completed
Phase 2
A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents
JPRN-UMIN000004026Digestive Disease Center, Showa University Nothern Yokohama Hospital200
Completed
N/A
In vivo isolation of circulating tumor cells from peripheral blood of patients with lung cancer by using a structured antibody-coated nanodetectorung cancer (non small cell lung cancer - NSCLC, stage I-IV)CancerMalignanat neoplasm of bronchus or lung, unspecified
ISRCTN55277999GILUPI GmbH (Germany)60
Completed
N/A
In vivo isolation of circulating tumor cells from peripheral blood of patients with breast cancer by using a structured antibody-coated nanodetectorBreast cancer (stage I-IV)CancerMalignant neoplasm of breast
ISRCTN66203697GILUPI GmbH (Germany)78
Recruiting
N/A
Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancer
JPRN-UMIN000024302Osaka University Graduate School of Medicine500